Clinical Trial Update: 11C-PIB PET Study in MESA at Columbia University

View source ↗

Summary

A completed clinical trial using the 11C-PIB PET tracer in the MESA cohort at Columbia University to study cognitive impairment and vascular diseases; detailed …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease
• Atherosclerosis
• Cognitive Impairment
• Vascular Disease

Snippet

Sponsor: José A. Luchsinger | Conditions: Cognitive Impairment, Vascular Diseases | Status: COMPLETED